Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to demonstrate if the use of Dermacyd can avoid the recurrence of bacterial vaginosis after three months of the standard treatment.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sanofi
• Treatments: Immune Sera

Criteria

Inclusion Criteria:

• Women in reproductive age

• Confirmed cure of bacterial vaginosis after treatment with oral metronidazole.

• Vaginal bacterioscopic examination negative for candida and trichomonas.

Exclusion Criteria:

• Pregnant or breastfeeding women

• Allergy to dermacyd

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.